{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:42:09Z","timestamp":1792208529646,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Robert E. Reed Gastrointestinal Oncology Research Foundation"},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["HT9425-24-1-0859"],"award-info":[{"award-number":["HT9425-24-1-0859"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-receipt of guideline-concordant treatment (GCT) in pancreatic ductal adenocarcinoma (PDAC) is associated with worse outcomes. Studies have identified associated factors, but less is known about how these factors co-occur within patient subgroups at the time of presentation to oncology care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a retrospective cohort study of patients with PDAC treated at two academic centers. Candidate variables available at presentation were selected\n                      <jats:italic>a priori<\/jats:italic>\n                      across demographic, clinical, socioeconomic, and healthcare utilization domains. Classification and regression tree (CART)\u00a0models were used to identify conditionally defined subgroups associated with non-receipt of GCT. Models were developed using an 80\/20 training\/test split with repeated cross-validation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 1040 patients, 337 (32.4%) did not receive GCT. In both unpruned and pruned models, Area Deprivation Index (ADI) defined the initial split. Among patients with ADI \u22657, non-receipt of GCT was more common among those entering care through the emergency department, with further stratification by race, social support, and timeliness of care. Among patients with ADI &lt;7, stratification was based on age, social support, and performance status. In sensitivity analyses excluding age, ADI remained the initial split, with downstream stratification based on cancer screening, insurance, social support, and albumin. The model demonstrated an area under the receiver operating characteristic curve (AUROC)\u00a0of 0.849 on the training set and 0.662 on the independent test set.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Non-receipt of GCT in PDAC is associated with distinct clinically identifiable patterns involving socioeconomic context, access to care, and patient vulnerability at presentation, highlighting potential targets for early intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-20369-x","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:01:36Z","timestamp":1786539696000},"page":"10115-10124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Determinants of Non-Receipt of Guideline-Concordant Treatment in Pancreatic Cancer: A Classification Tree Analysis"],"prefix":"10.1245","volume":"33","author":[{"given":"Manish","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Liapis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nritya","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Sirianno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4972-5139","authenticated-orcid":false,"given":"Annabelle L.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"issue":"4","key":"20369_CR1","doi-asserted-by":"publisher","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","volume":"4","author":"L Rahib","year":"2021","unstructured":"Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated projection of US cancer incidence and death to 2040. JAMA Network Open. 2021;4(4):e214708\u2013e214708. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.4708.","journal-title":"JAMA Network Open."},{"issue":"1","key":"20369_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin."},{"key":"20369_CR3","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma (version 2.2025). 2025. https:\/\/www.nccn.org."},{"issue":"8","key":"20369_CR4","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1007\/s11605-018-3742-9","volume":"22","author":"K Jaap","year":"2018","unstructured":"Jaap K, Fluck M, Hunsinger M, et al. Analyzing the impact of compliance with national guidelines for pancreatic cancer care using the National Cancer Database. J Gastrointest Surg. 2018;22(8):1358\u201364. https:\/\/doi.org\/10.1007\/s11605-018-3742-9.","journal-title":"J. Gastrointest Surg."},{"key":"20369_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17020170","author":"J Ejie","year":"2025","unstructured":"Ejie J, Ashraf Ganjouei A, Hernandez S, et al. Ongoing failure to deliver guideline-concordant care for patients with pancreatic cancer. Cancers (Basel). 2025. https:\/\/doi.org\/10.3390\/cancers17020170.","journal-title":"Cancers (Basel)."},{"issue":"6","key":"20369_CR6","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1200\/OP-25-00351","volume":"22","author":"J Herb","year":"2026","unstructured":"Herb J, Liao KP, Lin JK, et al. Racial and ethnic disparities in receipt of guideline-concordant pancreatic cancer care among older adults in the United States. JCO Oncol Pract. 2026;22(6):1075\u201386. https:\/\/doi.org\/10.1200\/OP-25-00351.","journal-title":"JCO Oncol Pract."},{"issue":"4","key":"20369_CR7","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.surg.2018.10.035","volume":"165","author":"DS Swords","year":"2019","unstructured":"Swords DS, Mulvihill SJ, Brooke BS, Skarda DE, Firpo MA, Scaife CL. Disparities in utilization of treatment for clinical stage I-II pancreatic adenocarcinoma by area socioeconomic status and race\/ethnicity. Surgery. 2019;165(4):751\u20139. https:\/\/doi.org\/10.1016\/j.surg.2018.10.035.","journal-title":"Surgery."},{"issue":"4","key":"20369_CR8","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1097\/xcs.0000000000001754","volume":"242","author":"AL Fonseca","year":"2026","unstructured":"Fonseca AL, Liapis I, Sanghera JS, et al. Biology vs barriers: the impact of socioeconomic disadvantage on overall survival in pancreatic cancer despite guideline-concordant treatment. J Am Coll Surg. 2026;242(4):1111\u201322. https:\/\/doi.org\/10.1097\/xcs.0000000000001754.","journal-title":"J Am Coll Surg."},{"issue":"5","key":"20369_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.hpb.2017.01.010","volume":"19","author":"M Bakens","year":"2017","unstructured":"Bakens M, Lemmens V, de Hingh I. Socio-economic status influences the likelihood of undergoing surgical treatment for pancreatic cancer in the Netherlands. HPB (Oxford). 2017;19(5):443\u20138. https:\/\/doi.org\/10.1016\/j.hpb.2017.01.010.","journal-title":"HPB (Oxford)."},{"issue":"4","key":"20369_CR10","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1097\/XCS.0000000000000957","volume":"238","author":"AL Fonseca","year":"2024","unstructured":"Fonseca AL, Ahmad R, Amin K, et al. Time kills: impact of socioeconomic deprivation on timely access to guideline-concordant treatment in foregut cancer. J Am Coll Surg. 2024;238(4):720\u201330. https:\/\/doi.org\/10.1097\/XCS.0000000000000957.","journal-title":"J Am Coll Surg."},{"issue":"4","key":"20369_CR11","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/cncr.24836","volume":"116","author":"TS Riall","year":"2010","unstructured":"Riall TS, Townsend CM Jr, Kuo YF, Freeman JL, Goodwin JS. Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process. Cancer. 2010;116(4):930\u20139. https:\/\/doi.org\/10.1002\/cncr.24836.","journal-title":"Cancer."},{"issue":"10","key":"20369_CR12","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1097\/MPA.0000000000001688","volume":"49","author":"F Zhu","year":"2020","unstructured":"Zhu F, Wang H, Ashamalla H. Racial and socioeconomic disparities in the treatments and outcomes of pancreatic cancer among different treatment facility types. Pancreas. 2020;49(10):1355\u201363. https:\/\/doi.org\/10.1097\/MPA.0000000000001688.","journal-title":"Pancreas."},{"issue":"26","key":"20369_CR13","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMp1802313","volume":"378","author":"AJH Kind","year":"2018","unstructured":"Kind AJH, Buckingham WR. Making neighborhood-disadvantage metrics accessible - The Neighborhood Atlas. N Engl J Med. 2018;378(26):2456\u20138. https:\/\/doi.org\/10.1056\/NEJMp1802313.","journal-title":"N Engl J Med."},{"issue":"5","key":"20369_CR14","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1245\/s10434-021-11258-6","volume":"29","author":"AL Fonseca","year":"2022","unstructured":"Fonseca AL, Khan H, Mehari KR, Cherla D, Heslin MJ, Johnston FM. Disparities in access to oncologic care in pancreatic cancer: a systematic review. Ann Surg Oncol. 2022;29(5):3232\u201350. https:\/\/doi.org\/10.1245\/s10434-021-11258-6.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"20369_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.amjsurg.2018.12.007","volume":"217","author":"O Moaven","year":"2019","unstructured":"Moaven O, Richman JS, Reddy S, Wang T, Heslin MJ, Contreras CM. Healthcare disparities in outcomes of patients with resectable pancreatic cancer. Am J Surg. 2019;217(4):725\u201331. https:\/\/doi.org\/10.1016\/j.amjsurg.2018.12.007.","journal-title":"Am J Surg."},{"issue":"2","key":"20369_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/SLA.0b013e3180691579","volume":"246","author":"KY Bilimoria","year":"2007","unstructured":"Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg. 2007;246(2):173\u201380. https:\/\/doi.org\/10.1097\/SLA.0b013e3180691579.","journal-title":"Ann Surg."},{"issue":"1","key":"20369_CR17","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1245\/s10434-021-10709-4","volume":"29","author":"AL Fonseca","year":"2022","unstructured":"Fonseca AL, Cherla D, Kothari AN, et al. Association of Medicaid expansion with pancreatic cancer treatment and outcomes: evidence from the National Cancer Database. Ann Surg Oncol. 2022;29(1):342\u201351. https:\/\/doi.org\/10.1245\/s10434-021-10709-4.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"20369_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0275116","volume":"17","author":"JH Klunder","year":"2022","unstructured":"Klunder JH, Panneman SL, Wallace E, et al. Prediction models for the prediction of unplanned hospital admissions in community-dwelling older adults: A systematic review. PLoS One. 2022;17(9):e0275116. https:\/\/doi.org\/10.1371\/journal.pone.0275116.","journal-title":"PLoS One."},{"issue":"2","key":"20369_CR19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.cjca.2021.09.004","volume":"38","author":"J Petch","year":"2022","unstructured":"Petch J, Di S, Nelson W. Opening the black box: the promise and limitations of explainable machine learning in cardiology. Can J Cardiol. 2022;38(2):204\u201313. https:\/\/doi.org\/10.1016\/j.cjca.2021.09.004.","journal-title":"Can J Cardiol."},{"key":"20369_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/nu17111903","author":"J Trujillano","year":"2025","unstructured":"Trujillano J, Servia L, Badia M, et al. Methodological review of classification trees for risk stratification: an application example in the obesity paradox. Nutrients. 2025. https:\/\/doi.org\/10.3390\/nu17111903.","journal-title":"Nutrients."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20369-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20369-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20369-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:22:42Z","timestamp":1792207362000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20369-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["20369"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20369-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}